金浩杰，上海市肿瘤研究所研究员，吉林大学生物技术理学学士，厦门大学医学院理学硕士，上海交通大学医学院获生物化学与分子生物学专业博士学位。

先后获得国家自然科学基金3项和国家科技重大专项课题任务1项，入选国家自然科学基金委员会与欧盟委员会“中欧人才项目”、上海市青年科技启明星、上海市人才发展资金、上海市卫生系统优秀青年医学人才等人才计划。近五年以第一作者或通讯作者（含并列）在Nature（2021封面论文；2019）、Gastroenterology、Journal of Hepatology、eLife和ACS Appl Mater Interfaces等国际学术期刊发表SCI论文16篇，以主要发明人申请肝癌诊断及治疗相关的国际国内发明专利3项。

1. 肿瘤微环境与肿瘤发生发展及耐药性的关系研究；

2. 肝癌联合治疗新靶点鉴定及临床转化研究；

3. 肝癌免疫调节靶点及联合治疗靶点筛选。

代表性论文：

1. Jin H, Shi Y, Lv Y, Yuan S, Ramirez CFA, Lieftink C, Wang L, Wang S, Wang C, Dias MH, Jochems F, Yang Y, Bosma A, Hijmans EM, de Groot MHP, Vegna S, Cui D, Zhou Y, Ling J, Wang H, Guo Y, Zheng X, Isima N, Wu H, Sun C, Beijersbergen RL, Akkari L, Zhou W*, Zhai B*, Qin W*, Bernards R*. EGFR activation limits response of liver cancer to lenvatinib. Nature. 2021 Jul;595(7869):730-734. (Cover story)

2. Jin H, Wang S, Zaal EA, Wang C, Wu H, Bosma A, Jochems F, Isima N, Jin G, Lieftink C, Beijersbergen R, Berkers CR*, Qin W*, Bernards R*. A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer. Elife. 2020 Oct 5;9:e56749.

3. Wang C#, Vegna S#, Jin H#, Benedict B#, Lieftink C, Ramirez C, de Oliveira RL, Morris B, Gadiot J, Wang W, du Chatinier A, Wang L, Gao D, Evers B, Jin G, Xue Z, Schepers A, Jochems F, Sanchez AM, Mainardi S, Te Riele H, Beijersbergen RL, Qin W*, Akkari L*, Bernards R*. Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature. 2019 Oct;574(7777):268-272.

4. Wu H, Wang C, Sun J, Sun L, Wan J, Wang S, Gu D, Yu C, Yang C, He J, Zhang Z, Lv Y, Wang H, Yao M, Qin W*, Wang C*, Jin H*. Self-Assembled and Self-Monitored Sorafenib/Indocyanine Green Nanodrug with Synergistic Antitumor Activity Mediated by Hyperthermia and Reactive Oxygen Species-Induced Apoptosis. ACS Appl Mater Interfaces. 2019 Nov 27;11(47):43996-44006.

5.Jin H, Wang C, Jin G, Ruan H, Gu D, Wei L, Wang H, Wang N, Arunachalam E, Zhang Y, Deng X, Yang C, Xiong Y, Feng H, Yao M, Fang J, Gu J, Cong W*, Qin W*. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Gastroenterology. 2017 Sep;153(3):799-811.e33.